Key points

  • Marcus Lemonis, the chief executive of Bed Bath & Beyond, Inc., bought $1.00 million of common stock on October 6th, 2026. The purchase covered 362,319 shares.
  • Every share came in at a single price of $2.76. The filing shows no range, which points to one execution level rather than a scaled series of fills.
  • The buy arrived in one filing. There is no cluster of insiders behind it and no second report to compare against.
  • The stock last printed at $4.35 against a market capitalization of $324,669,645. That is above the level the CEO paid.

Bed Bath & Beyond, Inc. (NASDAQ: BBBY) disclosed an open market purchase by its chief executive officer, Marcus Lemonis, dated October 6th, 2026. The transaction totaled $1.00 million across 362,319 shares.

The purchase price was $2.76 on both ends of the reported range. Shares last changed hands at $4.35, and the company carries a market capitalization of $324,669,645, which places this buy inside a small cap name rather than a large one.

What the filing shows

One Form 4, one insider, one price. Lemonis is listed in the role of CEO, and he is reported as an individual rather than an institution, so this is personal capital and not a fund allocation or a sponsor stake being topped up.

The absence of a price range matters more than it looks. When a Form 4 shows $2.76 at the low end and $2.76 at the high end, the shares were acquired at one level instead of being averaged across a session of partial fills. That tends to indicate a single block or a tightly bounded execution.

It is also worth being precise about what the filing does not contain. There is no stated reason for the purchase, no plan reference offered in these facts, and nothing in the document that speaks to intent beyond the trade itself. The record is the trade.

What the insider did

The size is clean and round at the dollar level: $1.00 million. Round dollar purchases by chief executives usually come from a decision to commit a set amount rather than to accumulate a set number of shares, and the odd share count of 362,319 is consistent with that pattern.

Context on breadth is thin by design. The count here is one filing. There is no second officer, no director, and no repeat purchase in the same window to lean on, so this is a single data point about a single person rather than a wave of buying across the insider roster.

Role carries weight in how these reports get read. A chief executive sits closest to operating detail, and the market generally treats CEO purchases as the most closely watched category of insider activity. That does not make any single purchase predictive, and it should not be read as one.

Where the price sits

Bed Bath & Beyond, Inc. last traded at $4.35. The CEO's fill was $2.76. On the published numbers, the stock is above the level the insider paid on October 6th, 2026.

Against a market capitalization of $324,669,645, a $1.00 million purchase is a meaningful personal commitment but a modest share of the company. Readers sizing this against the float should keep both figures in view at once, because the headline dollar number and the company's total value tell different parts of the story.

What that leaves

The clear facts are these: an individual, the chief executive, bought 362,319 shares for $1.00 million at $2.76 on October 6th, 2026, in one reported filing, in a retail catalog and mail order name capitalized at $324,669,645 and last quoted at $4.35.

The open questions are the ones the filing cannot answer. Whether other officers follow, whether the purchase repeats, and whether the price level holds are all future items. Single filings are weak evidence on their own, and they get stronger or weaker depending on what shows up behind them.

For anyone tracking this sector, the useful habit is to watch the filing count rather than the dollar figure. One buy is a note. A sequence is a pattern, and this company does not have one yet on the record reviewed here.

Sources: SEC Form 4 filings submitted via EDGAR and reviewed by InsiderBuying.com, covering the transaction date of October 6th, 2026.

Informational only, not investment advice.